Touyun Biotech Group Limited announced that Ms. Ha Amy has been appointed as the chief executive officer of the Company with effect from 3 January 2022. Ms. Ha (Former name: Ha Man), aged 50, is appointed as the chief executive officer of the Company with effect from 3 January 2022. Ms. Ha has extensive experiences in the financial management and investment.

From April 1998 to June 2014, she joined Bank of China (Hong Kong) Limited, her last position was assistant general manager in Corporate Business II at Corporate Banking and Financial Institutions. She was also Head of China Business within this period and she was mainly responsible for managing the business in China and major commodities transactions. From February 2015 to December 2021, she was a managing partner of Tenplus Venture Capital Management Company.

She has extensive experiences in the corporate strategic development and operations.